Independent Non Exe. Director: Rajesh Desai.

Glenmark's marketing portfolio as of December 2024 had 201 generic products authorised for distribution in the US. The company has 51 applications pending at various stages in the approval process.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Glenmark Pharmaceuticals Ltd share price was up by 0.13% from the previous closing price of ₹1,376.30. Who are peers of Glenmark Pharmaceuticals Ltd? The peers of Glenmark Pharmaceuticals Ltd ...

The Quarterly Results page of Glenmark Pharmaceuticals Ltd. presents the key result items, its comparison with the sector peers and its previous 5 Quarterly Results.

Alivus Life Sciences Ltd share price was up by 2.59% from the previous closing price of ₹940.95. Who are peers of Alivus Life Sciences Ltd? The peers of Alivus Life Sciences Ltd are Sun ...